These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38493910)

  • 21. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds.
    Bušić V; Katalinić M; Šinko G; Kovarik Z; Gašo-Sokač D
    Toxicol Lett; 2016 Nov; 262():114-122. PubMed ID: 27693733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studying kinetics of oxime-induced reactivation of malathion-inhibited cholinesterase].
    Iudin MA; Lantukhov DV; Vengerovich NG
    Eksp Klin Farmakol; 2013; 76(1):21-4. PubMed ID: 23461011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of (E)-2-(hydroxyimino)-N-(2 ((4methylpentyl)amino)ethyl)acetamide (KR-27425) as a non-pyridinium oxime reactivator of paraoxon-inhibited acetylcholinesterase.
    Vishakantegowda AG; Girmay BS; Shin JS; Lee JY; Ahn S; Jung YS
    Bioorg Med Chem Lett; 2023 Nov; 96():129504. PubMed ID: 37838342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The estimation of oxime efficiency is affected by the experimental design of phosphylated acetylcholinesterase reactivation.
    Maček Hrvat N; Zorbaz T; Šinko G; Kovarik Z
    Toxicol Lett; 2018 Sep; 293():222-228. PubMed ID: 29180286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why acetylcholinesterase reactivators do not work in butyrylcholinesterase.
    Wiesner J; Kríz Z; Kuca K; Jun D; Koca J
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):318-22. PubMed ID: 19874115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivation kinetics of a series of related bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase--Structure-activity relationships.
    Worek F; Wille T; Koller M; Thiermann H
    Biochem Pharmacol; 2012 Jun; 83(12):1700-6. PubMed ID: 22649796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pralidoxime-like reactivator with increased lipophilicity - Molecular modeling and in vitro study.
    Kuca K; Valle da Silva JA; Nepovimova E; Pham NL; Wu W; Valis M; Wu Q; França TCC
    Chem Biol Interact; 2023 Nov; 385():110734. PubMed ID: 37788753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of interaction of novel uncharged, centrally active reactivators with OP-hAChE conjugates.
    Radić Z; Sit RK; Garcia E; Zhang L; Berend S; Kovarik Z; Amitai G; Fokin VV; Barry Sharpless K; Taylor P
    Chem Biol Interact; 2013 Mar; 203(1):67-71. PubMed ID: 22975155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resurrection and Reactivation of Acetylcholinesterase and Butyrylcholinesterase.
    Franjesevic AJ; Sillart SB; Beck JM; Vyas S; Callam CS; Hadad CM
    Chemistry; 2019 Apr; 25(21):5337-5371. PubMed ID: 30444932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
    Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
    Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase.
    Winter M; Wille T; Musilek K; Kuca K; Thiermann H; Worek F
    Toxicol Lett; 2016 Feb; 244():136-142. PubMed ID: 26210933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivation potency of new group of acetylcholinesterase reactivators and their comparison with currently available oximes.
    Kuca K; Pícha J; Jun D
    Acta Medica (Hradec Kralove); 2006; 49(4):233-5. PubMed ID: 17438836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases.
    Sit RK; Radić Z; Gerardi V; Zhang L; Garcia E; Katalinić M; Amitai G; Kovarik Z; Fokin VV; Sharpless KB; Taylor P
    J Biol Chem; 2011 Jun; 286(22):19422-30. PubMed ID: 21464125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX.
    Chambers JE; Chambers HW; Funck KE; Meek EC; Pringle RB; Ross MK
    Chem Biol Interact; 2016 Nov; 259(Pt B):154-159. PubMed ID: 27387540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarin.
    Hrabinova M; Musilek K; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2006 Oct; 21(5):515-9. PubMed ID: 17194020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in silico identification of novel broad-spectrum antidotes for poisoning by organophosphate anticholinesterases.
    Habiballah S; Chambers J; Meek E; Reisfeld B
    J Comput Aided Mol Des; 2023 Dec; 37(12):755-764. PubMed ID: 37796381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors.
    Soukup O; Jun D; Tobin G; Kuca K
    Arch Toxicol; 2013 Apr; 87(4):711-9. PubMed ID: 23179755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the reactivation rates of acetylcholinesterase modified by structurally different organophosphates using novel pyridinium oximes.
    Bharate SB; Chao CK; Thompson CM
    Environ Toxicol Pharmacol; 2019 Oct; 71():103218. PubMed ID: 31302432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.